| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604446 | International Journal of Cardiology | 2017 | 32 Pages |
Abstract
6MWT was found to be reliable and valid in patients with mild-to-moderate CHF. Maximal exercise capacity, renal function and age were significant determinants of the best 6MWD. These findings strengthen the clinical utility of the 6MWT in CHF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicole H.M.K. Uszko-Lencer, Rafael Mesquita, Eefje Janssen, Christ Werter, Hans-Peter Brunner-La Rocca, Fabio Pitta, Emiel F.M. Wouters, Martijn A. Spruit,